BTIG cuts Medtronic stock target from USD 100.00 to USD 99.00

Published on 10/13/2026 at 13:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Medtronic reports on November 17, 2026 before the open. Medtronic stock costs EUR 82.49 in trading on October 13, 2026 at 1:44 p.m. CEST.

BTIG lowered Medtronic's target from USD 100.00 to USD 99.00 on October 12, 2026.
Medtronic reports its next earnings on November 17, 2026, before the open.
Medtronic stock costs EUR 82.49 at Lang & Schwarz on October 13, 2026 at 1:44 p.m. CEST.
The stock's home-market valuation was P/E 22.64 with USD 117.7 billion market capitalization on October 12, 2026.

Reinraumfertigung mit Technikern bei Montage medizintechnischer Präzisionsinstrumente — Medtronic plc (ISIN IE00BTN1Y115) Reinraum-Fertigung zeigt Techniker bei der Montage medizinischer Präzisionsinstrumente sorgfältig, Illustration mit AI erstellt.

BTIG lowered its price target for Medtronic plc (ISIN IE00BTN1Y115) from USD 100.00 to USD 99.00 on October 12, 2026, while keeping a Buy rating, as Markets Insider reported. Against the USD 91.93 NYSE price at the October 12, 2026 close, the revised target lies 7.69 percent higher. Medtronic was trading at EUR 82.49 at Lang & Schwarz on October 13, 2026 at 1:44 p.m. CEST.

The target remains above the market price

The USD 1.00 reduction leaves BTIG's target 7.69 percent above the USD 91.93 home-market price, a smaller gap than the former USD 100.00 target. The report also keeps the Buy rating, giving the analyst action two distinct elements for investors to track.

Range and trading position

Medtronic's NYSE price stood at USD 91.93 on October 12, 2026 at 4:00 p.m. ET. The 52-week range was USD 73.31 to USD 106.33, placing the stock 13.55 percent below its high and 25.40 percent above its low. Trading volume reached 36,561,952 shares against an average of 14,043,171.

The next earnings report is scheduled for November 17, 2026, before the open, as Gekko reported. That date gives the market a defined event ahead of which analyst expectations can be measured.

Valuation and reporting date

Medtronic had a market capitalization of USD 117.7 billion, a P/E ratio of 22.64 and a dividend yield of 0.03 percent on October 12, 2026. The combination places the BTIG target revision alongside a large established medical-device company rather than a small-cap trading story.

Comparison with peers

Medtronic plc: P/E 22.64, market capitalization USD 117.7 billion

Abbott Laboratories (NYSE, USD): plus 2.23 percent, P/E 32.74, market capitalization USD 176.2 billion

Boston Scientific (NYSE, USD): plus 2.60 percent, P/E 17.82, market capitalization USD 65.2 billion

EUR 82.49 at Lang & Schwarz

Medtronic was trading at EUR 82.49 at Lang & Schwarz on October 13, 2026 at 1:44 p.m. CEST. Its separate NYSE quote was USD 91.93 on October 12, 2026 at 4:00 p.m. ET. The further course of trading is shown by the continuously updated real-time quote of Medtronic stock.